SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Laura-Maria Krabbe, Vitaly Margulis, Yair Lotan, Prognostic Role of Cell Cycle and Proliferative Markers in Clear Cell Renal Cell Carcinoma, Urologic Clinics of North America, 2016, 43, 1, 105

    CrossRef

  2. 2
    Lei Zhang, Lin Yao, Xuesong Li, Michael A.S. Jewett, Zhisong He, Liqun Zhou, Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment, Journal of the Formosan Medical Association, 2015,

    CrossRef

  3. 3
    Koji Matsuo, Kiyoshi Yoshino, Kosei Hasegawa, Ryusuke Murakami, Yuji Ikeda, Sosuke Adachi, Kosuke Hiramatsu, Takuhei Yokoyama, Masato Nishimura, Todd B. Sheridan, Takayuki Enomoto, Keiichi Fujiwara, Noriomi Matsumura, Ikuo Konishi, Christina Fotopoulou, Lynda D. Roman, Anil K. Sood, Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion, Gynecologic Oncology, 2015, 136, 2, 198

    CrossRef

  4. 4
    Bishoy A. Gayed, Ramy F. Youssef, Aditya Bagrodia, Oussama M. Darwish, Payal Kapur, Arthur Sagalowsky, Yair Lotan, Vitaly Margulis, Ki67 is an independent predictor of oncological outcomes in patients with localized clear-cell renal cell carcinoma, BJU International, 2014, 113, 4
  5. 5
    Michael Belsante, Oussama Darwish, Ramy Youssef, Aditya Bagrodia, Payal Kapur, Arthur I. Sagalowsky, Yair Lotan, Vitaly Margulis, Lymphovascular invasion in clear cell renal cell carcinoma—Association with disease-free and cancer-specific survival, Urologic Oncology: Seminars and Original Investigations, 2014, 32, 1, 30.e23

    CrossRef

  6. 6
    Gan Yu, Heng Li, Ji Wang, Kiranmai Gumireddy, Anping Li, Weimin Yao, Kun Tang, Wei Xiao, Junhui Hu, Haibing Xiao, Bin Lang, Zhangqun Ye, Qihong Huang, Hua Xu, miRNA-34a Suppresses Cell Proliferation and Metastasis by Targeting CD44 in Human Renal Carcinoma Cells, The Journal of Urology, 2014, 192, 4, 1229

    CrossRef

  7. 7
    Hong-fei Du, Li-ping Ou, Xue-dong Song, Yan-ru Fan, Xue Yang, Bing Tan, Zhen Quan, Chun-Li Luo, Xiao-hou Wu, Nuclear factor-κB signaling pathway is involved in phospholipase Cε-regulated proliferation in human renal cell carcinoma cells, Molecular and Cellular Biochemistry, 2014, 389, 1-2, 265

    CrossRef

  8. 8
    Naoyuki Fujita, Takatsugu Okegawa, Yuichi Terado, Mitsuhiro Tambo, Eiji Higashihara, Kikuo Nutahara, Serum level and immunohistochemical expression of vascular endothelial growth factor for the prediction of postoperative recurrence in renal cell carcinoma, BMC Research Notes, 2014, 7, 1, 369

    CrossRef

  9. 9
    B. Santiago-Agredano, J. Álvarez-Kindelán, P. Font-Ugalde, A. Blanca-Pedregosa, A. López-Beltrán, M.J. Requena-Tapia, Prognostic value of microvascular invasion in predicting survival in renal cell carcinoma, Actas Urológicas Españolas (English Edition), 2013, 37, 8, 504

    CrossRef

  10. 10
    L Fan, P Li, Z Yin, G Fu, D J Liao, Y Liu, J Zhu, Y Zhang, L Wang, Q Yan, Y Guo, C Shao, G Huang, Z Wang, Ribosomal s6 protein kinase 4: a prognostic factor for renal cell carcinoma, British Journal of Cancer, 2013, 109, 5, 1137

    CrossRef

  11. 11
    B. Santiago-Agredano, J. Álvarez-Kindelán, P. Font-Ugalde, A. Blanca-Pedregosa, A. López-Beltrán, M.J. Requena-Tapia, Valor pronóstico de la invasión microvascular en la predicción de la supervivencia en el carcinoma de células renales, Actas Urológicas Españolas, 2013, 37, 8, 504

    CrossRef

  12. 12
    Andrew Chi, Samir P. Shirodkar, Diogo O. Escudero, Obi O. Ekwenna, Travis J. Yates, Rajinikanth Ayyathurai, Michael Garcia-Roig, Jeffrey C. Gahan, Murugesan Manoharan, Vincent G. Bird, Vinata B. Lokeshwar, Molecular characterization of kidney cancer, Cancer, 2012, 118, 9
  13. 13
    Nils Kroeger, Edward N. Rampersaud, Jean-Jacques Patard, Tobias Klatte, Frédéric D. Birkhäuser, Shahrokh F. Shariat, Hervé Lang, Nathalie Rioux-Leclerq, Mesut Remzi, Nazy Zomorodian, Fairooz F. Kabbinavar, Arie S. Belldegrun, Allan J. Pantuck, Prognostic Value of Microvascular Invasion in Predicting the Cancer Specific Survival and Risk of Metastatic Disease in Renal Cell Carcinoma: A Multicenter Investigation, The Journal of Urology, 2012, 187, 2, 418

    CrossRef

  14. 14
    Sergio Bracarda, Christopher Logothetis, Cora N. Sternberg, Stéphane Oudard, Current and emerging treatment modalities for metastatic castration-resistant prostate cancer, BJU International, 2011, 107,
  15. 15
    Maxine Sun, Shahrokh F. Shariat, Christopher Cheng, Vincenzo Ficarra, Masaru Murai, Stéphane Oudard, Allan J. Pantuck, Richard Zigeuner, Pierre I. Karakiewicz, Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review, European Urology, 2011, 60, 4, 644

    CrossRef

  16. 16
    Matthew D. Katz, Maria F. Serrano, Peter A. Humphrey, Robert L. Grubb, Ted A. Skolarus, Feng Gao, Adam S. Kibel, The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection, Urologic Oncology: Seminars and Original Investigations, 2011, 29, 6, 738

    CrossRef

  17. 17
    Tahsin Turunc, Nebil Bal, Ayhan Dirim, Baris Kuzgunbay, Umit Gul, Hakan Ozkardes, Maspin Expression in Renal Cell Carcinoma and Its Correlation with Clinicopathologic Parameters, Urology, 2010, 76, 3, 765.e8

    CrossRef

  18. 18
    P.J. Goebell, B. Keck, S. Wach, B. Wullich, Stellenwert von Biomarkern in der Urologie, Der Urologe, 2010, 49, 4, 547

    CrossRef

  19. 19
    Christian Eichelberg, Kerstin Junker, Börje Ljungberg, Holger Moch, Diagnostic and Prognostic Molecular Markers for Renal Cell Carcinoma: A Critical Appraisal of the Current State of Research and Clinical Applicability, European Urology, 2009, 55, 4, 851

    CrossRef

  20. 20
    Rafael A. Medina López, José M. Conde Sánchez, Carmen B. Congregado Ruiz, Raquel González Resina, Salvador Mármol Navarro, Francisco J. Torrubia Romero, Factores pronósticos del carcinoma de células renales, Actas Urológicas Españolas, 2009, 33, 5, 575

    CrossRef

  21. 21
    Harriet M Kluger, Summar F Siddiqui, Cesar Angeletti, Mario Sznol, William K Kelly, Annette M Molinaro, Robert L Camp, Classification of renal cell carcinoma based on expression of VEGF and VEGF receptors in both tumor cells and endothelial cells, Laboratory Investigation, 2008, 88, 9, 962

    CrossRef

  22. 22
    Mark Nogueira, Hyung L. Kim, Molecular markers for predicting prognosis of renal cell carcinoma, Urologic Oncology: Seminars and Original Investigations, 2008, 26, 2, 113

    CrossRef

  23. 23
    Paolo Gontero, Giovanni Ceratti, Sandro Guglielmetti, Antonella Andorno, Carlo Terrone, Daniele Bonvini, Fabrizio Faggiano, Alessandro Tizzani, Bruno Frea, Guido Valente, Prognostic factors in a prospective series of papillary renal cell carcinoma, BJU International, 2008, 102, 6
  24. 24
    Esin Yildiz, Semih Ayan, Fahrettin Goze, Gokhan Gokce, Emin Y. Gultekin, Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma, BJU International, 2008, 101, 6
  25. 25
    Tobias Klatte, Malte Böhm, Thomas Nelius, Stephanie Filleur, Frank Reiher, Ernst Peter Allhoff, Evaluation of peri-operative peripheral and renal venous levels of pro- and anti-angiogenic factors and their relevance in patients with renal cell carcinoma, BJU International, 2007, 100, 1
  26. 26
    Mark Slevin, Jurek Krupinski, John Gaffney, Sabine Matou, David West, Horace Delisser, Rashmin C. Savani, Shant Kumar, Hyaluronan-mediated angiogenesis in vascular disease: Uncovering RHAMM and CD44 receptor signaling pathways, Matrix Biology, 2007, 26, 1, 58

    CrossRef

  27. 27
    Nguyen Ba Phuoc, Hidetoshi Ehara, Takahiro Gotoh, Masahiro Nakano, Shigeaki Yokoi, Takashi Deguchi, Yoshinobu Hirose, Immunohistochemical Analysis with Multiple Antibodies in Search of Prognostic Markers for Clear Cell Renal Cell Carcinoma, Urology, 2007, 69, 5, 843

    CrossRef

  28. 28
    Matthew K. Tollefson, R. Houston Thompson, Yuri Sheinin, Christine M. Lohse, John C. Cheville, Bradley C. Leibovich, Eugene D. Kwon, Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other, Cancer, 2007, 110, 4
  29. 29
    Brett Delahunt, Peter B. Bethwaite, John N. Nacey, Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype, Pathology, 2007, 39, 5, 459

    CrossRef

  30. 30
    Robert Houston Thompson, Michael L. Blute, Amy E. Krambeck, Christine M. Lohse, James S. Magera, Bradley C. Leibovich, Eugene D. Kwon, Igor Frank, John C. Cheville, Patients With pT1 Renal Cell Carcinoma Who Die From Disease After Nephrectomy May Have Unrecognized Renal Sinus Fat Invasion, The American Journal of Surgical Pathology, 2007, 31, 7, 1089

    CrossRef

  31. 31
    Zhong Jiang, Prognostic biomarkers in renal cell carcinoma, Expert Review of Molecular Diagnostics, 2007, 7, 3, 293

    CrossRef

  32. 32
    Gordana Djordjevic, Vladimir Mozetic, Danijela Vrdoljak Mozetic, Vanja Licul, Koviljka Matusan Ilijas, Elvira Mustac, Romano Oguic, Zeljko Fuckar, Nives Jonjic, Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma, Pathology - Research and Practice, 2007, 203, 2, 99

    CrossRef

  33. 33
    Stephan Störkel, Glen Kristiansen, Holger Moch, The Importance of Pathology and Genetics for the Diagnosis and Therapy of Renal Cell Carcinoma, European Urology Supplements, 2007, 6, 10, 603

    CrossRef

  34. 34
    Eui Jung Moon, David M. Brizel, Jen–Tsan Ashley Chi, Mark W. Dewhirst, The Potential Role of Intrinsic Hypoxia Markers as Prognostic Variables in Cancer, Antioxidants & Redox Signaling, 2007, 9, 8, 1237

    CrossRef

  35. 35
    JAN JACOBSEN, KJELL GRANKVIST, TORGNY RASMUSON, BÖRJE LJUNGBERG, Different isoform patterns for vascular endothelial growth factor between clear cell and papillary renal cell carcinoma, BJU International, 2006, 97, 5
  36. 36
    László Kopper, József Tímár, Genomics of renal cell cancer — Does it provide breakthrough?, Pathology & Oncology Research, 2006, 12, 1, 5

    CrossRef

  37. 37
    Olivier Rouvière, Raymonde Bouvier, Sylvie Négrier, Lionel Badet, Denis Lyonnet, Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up?, Nature Clinical Practice Oncology, 2006, 3, 4, 200

    CrossRef